Answers are grounded in this paper and cite their sources.
. These findings indicated that HDAC1 is a critical promoter of LUAD progression, acting at least in part through β‑catenin nuclear accumulation. This provided a mechanistic rationale for targeting the HDAC1/β‑catenin axis as a potential epigenetic therapeutic strategy in LUAD.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: